Global Phase I CRO (Clinical Research Organization) Benchmarking Report 2021
Dublin, May 21, 2021 (GLOBE NEWSWIRE) -- The "Phase I CRO Benchmarking (13th Ed.)" report has been added to ResearchAndMarkets.com's offering.
We know many sponsor companies turn to CROs for the heavy lifting of their clinical development programs.
Finding the service provider best suited to meet trial needs and ensuring that the provider can meet performance expectations constitutes the onerous and time-intensive decision-making process that companies take on if they need to outsource any or all components of their clinical trials. In other words, companies need a reliable resource to shed light on CRO selection and CRO performance.
This report is that resource. We aim to alleviate some of the stress associated with this process by enhancing your ability to make informed decisions.
This report includes insights from 191 experienced Phase I outsourcers and more than 500 service provider encounters.
What does the outsourcing community consider when it comes to CRO selection? Which providers are favoured by respondents and where do providers fall regarding cost perceptions? Explore these measures and more help to frame all that goes into CRO selection. Whether you're a sponsor or provider, use this research to glean what you need to make the best decisions possible for your clinical development programs and service offerings.
What You Will Learn:
Sponsors:
Learn which service providers your company should keep in mind for your clinical development programs by identifying how your peers' expectations line up with individual CROs
Better understand CRO customer loyalty based on overall customer satisfaction, willingness to recommend and likelihood to use again
Find out which Phase I-specific attributes motivate outsourcing selection, and evaluate verbatim responses from recent customers on CRO performance
Service Providers:
Contrast how your company measures up against your competitors across 22 attributes grouped by Budget, Delivery, Staff, Accessibility, and Services
Discover how to enhance your marketing messaging by concentrating on the areas in which customers say you shine compared to the competition
Determine which factors influence sponsor outsourcing preferences, and which factors are becoming more significant for future outsourcing
Major Topics:
Service Provider Selection Process
Service Provider Perceptions and Interactions
Service Provider Performance and Loyalty
Company Service Quality Profiles
Key Topics Covered:
1. Service Provider Selection Process
Primary Section Takeaways
Preferred Provider Agreements
Selection Attributes
Use of Outside Consultants for CRO Identification and Selection
Select Respondent Comments
2. Service Provider Perceptions and Interactions
Primary Section Takeaways
Phase I Leadership, Familiarity, and Use
Service Provider Preference
Service Provider Preference among Users
Cost Perceptions
Cost Experience among Users
Summary Table
3. Service Provider Performance and Loyalty
Primary Section Takeaways
A Note on Harvey Ball Calculations
Performance Across Service Providers
Budget Factors
Delivery Factors
Staff Characteristics
Accessibility
Services
Customer Loyalty: 2021
Customer Loyalty: 3-Year Rolling Average
4. Company Service Quality Profiles
Celerion
Covance
Eurofins
Frontage
ICON
IQVIA
Medpace
Parexel
PPD
PRA
Syneos Health
Worldwide Clinical Trials
5. Study Data
Phase I Leaders, Unprompted
Other Responses
Phase I Leaders, Prompted
Service Provider Familiarity
Service Provider Usage
Service Provider Preference
Service Provider Differentiation
Service Provider Cost Perceptions
Use of Preferred Providers
Number of Preferred Providers
Selection Drivers: Selecting among Preferred Providers
Preferred Provider Attributes Gaining Importance
Selection Drivers: When Not Using Preferred Providers
Selection Drivers: No Preferred Providers
Service Provider Attributes Gaining Importance: No Preferred Providers
Use of Outside Consultants for CRO Identification and Selection
Outside Consultant Assistance
6. Service Provider Drill-downs
Algorithme Pharma (Altasciences)
BioPharma Services Inc.
Bioskin
Biotrial
Catalyst Clinical Research
Celerion
CHDR
Covance
CTI Clinical Trial & Consulting
DCRI-Duke
Eurofins
Frontage
High Point Clinical Trial Center
ICON
Innovaderm
IQVIA
Lambda
Linical Accelovance
Medpace
Medsource
NAMSA
Novotech
Nuvisan
Ora
Parexel
Pharm-Olam International
PharPoint
PPD
PRA
QPS
Quotient Clinical
Rho
SGS Life Sciences
Simbec-Orion
Syneos Health
Synteract
TKL Research
Vince & Associates (Altasciences)
WCCT Global
Worldwide Clinical Trials
7. Demographics
Company Type
Headquarters Location
Office Location
Job Title
Decision-making Responsibility
Outsourcing Involvement by Phase
Involvement in Clinical Development
Therapeutic Areas of Responsibility
Years of Industry Experience
Age
For more information about this report visit https://www.researchandmarkets.com/r/4z9k1z
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900